A cysteine to serine substitution at amino acid 23 in the 5-HT2C recep
tor gene alters the pharmacological properties of the protein. We inve
stigated this polymorphism in subjects with schizophrenia resistant to
conventional neuroleptic drugs, and analysed our data for allelic ass
ociation between the disease state or clinical response to the atypica
l antipsychotic drug, clozapine. Ninety percent of subjects who had on
e or more 5-HT(2C)ser alleles (19/21) were classified as clozapine res
ponders compared with 59% (84/141) without this allele (chi(2) = 7.7,
p = 0.005), suggesting that this mutation is a predictor of good respo
nse to clozapine. There was no association between schizophrenia and t
he 5-HT(2C)ser allele, but our results indicate that the 5-HT2C recept
or may contain the major site of action through which clozapine mediat
es its antipsychotic effects.